ProfileGDS4718 / 236038_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 17% 91% 14% 23% 5% 16% 19% 27% 19% 19% 22% 13% 12% 9% 25% 27% 17% 4% 12% 19% 24% 29% 21% 21% 13% 34% 6% 20% 14% 12% 31% 23% 18% 20% 9% 10% 21% 15% 87% 19% 16% 38% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9527614
GSM549102patient 115, normal, homogenized [OPG study]4.0425317
GSM549104patient 119, normal, homogenized [OPG study]9.4314391
GSM549108patient 138, normal, homogenized [OPG study]3.9625214
GSM549119patient 077, normal, homogenized [OPG study]4.2654123
GSM549133patient 032, cancer, homogenized [OPG study]3.533215
GSM549139patient 042, cancer, homogenized [OPG study]3.972916
GSM549099patient 107, normal, homogenized [OPG study]4.1256119
GSM549109patient 139, normal, homogenized [OPG study]4.4494627
GSM549110patient 046, normal, homogenized [OPG study]4.1181519
GSM549114patient 063, normal, homogenized [OPG study]4.0696519
GSM549122patient 082, normal, homogenized [OPG study]4.2275722
GSM549134patient 033, cancer, homogenized [OPG study]3.8885613
GSM549136patient 036, cancer, homogenized [OPG study]3.818212
GSM549140patient 044, cancer, homogenized [OPG study]3.703359
GSM549111patient 047, normal, homogenized [OPG study]4.3016425
GSM549113patient 057, normal, homogenized [OPG study]4.3611827
GSM549132patient 031, cancer, homogenized [OPG study]4.0164717
GSM549137patient 038, cancer, homogenized [OPG study]3.524034
GSM549142patient 047, cancer, homogenized [OPG study]3.9171712
GSM549100patient 110, normal, homogenized [OPG study]4.1246119
GSM549107patient 135, normal, homogenized [OPG study]4.2673124
GSM549115patient 068, normal, homogenized [OPG study]4.4423329
GSM549116patient 072, normal, homogenized [OPG study]4.1697321
GSM549120patient 078, normal, homogenized [OPG study]4.170521
GSM549131patient 030, cancer, homogenized [OPG study]3.8461413
GSM549118patient 074, normal, homogenized [OPG study]4.6915234
GSM549129patient 027, cancer, homogenized [OPG study]3.63646
GSM549123patient 088, normal, homogenized [OPG study]4.1364620
GSM549124patient 006, cancer, homogenized [OPG study]3.9601214
GSM549126patient 015, cancer, homogenized [OPG study]3.85112
GSM549128patient 025, cancer, homogenized [OPG study]4.5786231
GSM549103patient 117, normal, homogenized [OPG study]4.3197523
GSM549117patient 073, normal, homogenized [OPG study]4.061418
GSM549138patient 041, cancer, homogenized [OPG study]4.1044520
GSM549141patient 045, cancer, homogenized [OPG study]3.680059
GSM549130patient 028, cancer, homogenized [OPG study]3.7793310
GSM549101patient 111, normal, homogenized [OPG study]4.1834121
GSM549105patient 128, normal, homogenized [OPG study]3.988615
GSM549106patient 134, normal, homogenized [OPG study]8.9385787
GSM549112patient 048, normal, homogenized [OPG study]4.0955419
GSM549125patient 011, cancer, homogenized [OPG study]4.0094516
GSM549127patient 024, cancer, homogenized [OPG study]4.9048938
GSM549135patient 035, cancer, homogenized [OPG study]3.8561113